SCHEMBL670887

SCHEMBL670887

O=C1CC=CC=N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4237662 0.97
SCHEMBL30812390 0.74
SCHEMBL1760200 0.70
Bromide SCHEMBL8931675 0.68
SCHEMBL2297737 0.67
SCHEMBL30160680 0.65
SCHEMBL5879546 0.65
SCHEMBL31662773 0.65
SCHEMBL7447410 0.63
SCHEMBL1515000 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 335 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115772114-B Method for synthesizing 2, 3-dihydropyridinone by one-pot catalysis of iodopyridinium salt 成都理工大学 2024-09-06 CN claimed
CN-115710281-B Isoxazolo [5,4-b ] pyridine FLT3 inhibitor and preparation method and application thereof 南京中医药大学 2024-05-17 CN claimed
CN-117836297-A (S) -1- (5- ((pyridin-3-yl) thio) pyrazin-2-yl) -4'H,6' H-spiro [ piperidine-4, 5 '-pyrrolo [1,2-B ] pyrazol ] -4' -amine derivatives and similar compounds as SHP2 inhibitors for the treatment of, for example, cancer 国家化学成分收集和筛选中心 2024-04-05 CN claimed
CN-115368357-B Synthesis method of calcium channel enhancer SAK3 intermediate 南京市天铭医药科技有限公司 2023-09-29 CN claimed
CN-115772114-A Method for synthesizing 2, 3-dihydropyridone by one-pot method under catalysis of iodopyridinium salt 成都理工大学 2023-03-10 CN claimed
CN-115710281-A Isoxazolo [5,4-b ] pyridine FLT 3inhibitor and preparation method and application thereof 南京中医药大学 2023-02-24 CN claimed
CN-110678472-B 2-oxothiazole derivatives as A2A inhibitors and compounds for the treatment of cancer 伊忒欧斯比利时股份公司 2023-01-24 CN claimed
WO-2023280132-A1 CRYSTAL FORM OF OXODIHYDROIMIDAZOPYRIDINE COMPOUND AND PREPARATION METHOD THEREFOR 苏州晶云药物科技股份有限公司 2023-01-12 WO claimed
CN-115368357-A Synthetic method of calcium channel enhancer SAK3 intermediate 南京市天铭医药科技有限公司 2022-11-22 CN claimed
EP-3802547-A1 PROCESS FOR PRODUCING COMPOUNDS CONTAINING AN OXAZOLOPYRIDINONE FUNCTIONAL GROUP Biocidal Alternative Solutions (BE) 2021-04-14 EP claimed
US-20100204236-A1 Substituted imidazoles as bombesin receptor subtype-3 modulators MERCK SHARP & DOHME CORP. 2010-08-12 US claimed
EP-2083623-A1 SUBSTITUTED IMIDAZOLES AS BOMBESIN RECEPTOR SUBTYPE-3 MODULATORS Merck & Co., Inc. (US) 2009-08-05 EP claimed
EP-1729772-A4 HETEROARYL PIPERIDINE GLYCINE TRANSPORTER INHIBITORS MERCK & CO INC (US) 2009-05-27 EP claimed
WO-2008051405-A1 SUBSTITUTED IMIDAZOLES AS BOMBESIN RECEPTOR SUBTYPE-3 MODULATORS MERCK & CO., INC. (US) 2008-05-02 WO claimed
CN-101160307-A Benzoxazole carboxamides for the treatment of CINV and IBS-D AMR TECHNOLOGY INC (US) 2008-04-09 CN claimed
US-20070254880-A1 Heteroaryl Piperidine Glycine Transporter Inhibitors MERCK SHARP & DOHME LLC 2007-11-01 US claimed
CN-1933836-A Heteroaryl piperidine glycine transporter inhibitors MERCK & CO INC (US) 2007-03-21 CN claimed
EP-1729772-A2 HETEROARYL PIPERIDINE GLYCINE TRANSPORTER INHIBITORS Merck and Co., Inc. (US) 2006-12-13 EP claimed
WO-2005094514-A2 HETEROARYL PIPERIDINE GLYCINE TRANSPORTER INHIBITORS MERCK & CO., INC. (US) 2005-10-13 WO claimed
CN-1468241-A Heterocyclic compounds as ligands of the gabaa receptor 2004-01-14 CN claimed